UPDATE 1-Amgen 1st-quarter profit boosted by R&D, drug prices

April 21, 2015 9:10 PM

3 0

April 21 (Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, driven by price increases for its biggest-selling drugs, as well as lower spending on research and development.

Amgen shares, which rose 1.5 percent in regular trading, were up another 2 percent at $171.85 after hours.

Also read: Deutsche Bank Posts Unexpected Profit on Lower Overhaul Costs

Read more

To category page